Post by Gilead Sciences on X
Gilead Sciences@GileadSciences
X#GileadNews: At #AIDS2026, in collaboration with @Merck, we’re presenting new data from our Phase 3 trials evaluating an investigational long-acting oral treatment for adults with virologically suppressed HIV.
Read the full press release here: t.co
14 likes0 repliesPosted Jul 21, 2026